Abstract:Our group has developed a subretinal microphotodiode array for restoration of vision. In a clinical pilot study the array has been implanted in 11 patients suffering from photoreceptor degenerations. Here we present promising results from some of those patients where the retinal tissue above the chip was functional and the implant fulfilled its expected function. A spatial resolution of approximately 0.3 cycles/degree could be achieved with fine stripe patterns. In one subject where the implant had been placed… Show more
“…1 Individuals suffering outer retinal blindness, such as late stage retinitis pigmentosa (RP) or dry age-related macular degeneration, may be able to recover some visual feedback with use of a retinal prosthesis. [2][3][4] These devices stimulate the remaining cells in the inner retina to convey signals to the visual cortex. In theory, stimulating remaining cells in a pattern corresponding to visual stimuli could create visual percepts resembling those stimuli.…”
II Study Group 3 PURPOSE. We studied the capabilities of the Argus II retinal prosthesis for guiding fine hand movement, and demonstrated and quantified guidance improvement when using the device over when not using the device for progressively less predictable trajectories.
METHODS.A total of 21 patients with retinitis pigmentosa (RP), remaining vision no more than bare light perception, and an implanted Argus II epiretinal prostheses used a touchscreen to trace white paths on black backgrounds. Sets of paths were divided into three categories: right-angle/single-turn, mixedangle/single-turn, and mixed-angle/two-turn. Subjects trained on paths by using prosthetic vision and auditory feedback, and then were tested without auditory feedback, with and without prosthetic vision. Custom software recorded position and timing information for any contact that subjects made with the screen. The area between the correct path and the trace, and the elapsed time to trace a path were used to evaluate subject performance.RESULTS. For right-angle/single-turn sets, average tracing error was reduced by 63% and tracing time increased by 156% when using the prosthesis, relative to residual vision. With mixedangle/single-turn sets, error was reduced by 53% and time to complete tracing increased by 184%. Prosthesis use decreased error by 38% and increased tracing time by 252% for paths that incorporated two turns.
CONCLUSIONS.Use of an epiretinal visual prosthesis can allow RP patients with no more than bare light perception to guide fine hand movement visually. Further, prosthetic input tends to make subjects slower when performing tracing tasks, presumably reflecting greater effort. (ClinicalTrials.gov number, NCT00407602.) (Invest Ophthalmol Vis Sci. 2012;53:5095-5101)
“…1 Individuals suffering outer retinal blindness, such as late stage retinitis pigmentosa (RP) or dry age-related macular degeneration, may be able to recover some visual feedback with use of a retinal prosthesis. [2][3][4] These devices stimulate the remaining cells in the inner retina to convey signals to the visual cortex. In theory, stimulating remaining cells in a pattern corresponding to visual stimuli could create visual percepts resembling those stimuli.…”
II Study Group 3 PURPOSE. We studied the capabilities of the Argus II retinal prosthesis for guiding fine hand movement, and demonstrated and quantified guidance improvement when using the device over when not using the device for progressively less predictable trajectories.
METHODS.A total of 21 patients with retinitis pigmentosa (RP), remaining vision no more than bare light perception, and an implanted Argus II epiretinal prostheses used a touchscreen to trace white paths on black backgrounds. Sets of paths were divided into three categories: right-angle/single-turn, mixedangle/single-turn, and mixed-angle/two-turn. Subjects trained on paths by using prosthetic vision and auditory feedback, and then were tested without auditory feedback, with and without prosthetic vision. Custom software recorded position and timing information for any contact that subjects made with the screen. The area between the correct path and the trace, and the elapsed time to trace a path were used to evaluate subject performance.RESULTS. For right-angle/single-turn sets, average tracing error was reduced by 63% and tracing time increased by 156% when using the prosthesis, relative to residual vision. With mixedangle/single-turn sets, error was reduced by 53% and time to complete tracing increased by 184%. Prosthesis use decreased error by 38% and increased tracing time by 252% for paths that incorporated two turns.
CONCLUSIONS.Use of an epiretinal visual prosthesis can allow RP patients with no more than bare light perception to guide fine hand movement visually. Further, prosthetic input tends to make subjects slower when performing tracing tasks, presumably reflecting greater effort. (ClinicalTrials.gov number, NCT00407602.) (Invest Ophthalmol Vis Sci. 2012;53:5095-5101)
“…In comparison to the epiretinal approach, the use of a subretinal prosthesis does not require any additional fixation tool, as the stimulator remains in stable position after insertion into the subretinal space [20,21]. However, the EPIRET3 approach allows a complete intraocular implantation with wireless energy and signal supply from outside, while the subretinal prostheses require a transchoroidal and transscleral cable connection to the energy source outside the eyeball, which may reveal a certain risk potential in this area.…”
The FA findings confirm our previous results on the safety of the EPIRET3 system, which was tolerated in all patients but revealed a certain risk profile in regard to the stimulator fixation. While there was no evidence for newly occurred CME or CNV during the follow-up visits, nevertheless gliosis or even PVR reaction at the tack's fixation site suggests the need to develop alternative fixation procedures of epiretinal stimulators.
“…25 While image acquisition is solely intraocular, a cable connecting the implant to a subdermal power control unit, which charges wirelessly through a handheld control unit, enables light-sensitivity adjustment. 26,27 Early models with a transdermal power supply limited the study to 126 days. However, wireless power supply has eliminated the time limitation in later trials.…”
Degenerative retinal diseases may lead to significant loss of vision. Age-related macular degeneration (AMD) and retinitis pigmentosa (RP), which eventually affect the photoreceptors, are the two most common retinal degenerative diseases. Once the photoreceptorcells are lost, there are no known effective therapies for AMD or RP. The concept of retinal prosthesis is to elicit neural activity in the remaining retinal neurons by detecting light and converting it into electrical stimuli using artificial devices. Subretinal, epiretinal, and other retinal prostheses implants are currently designed to restore functional vision in retinal degenerative diseases. In this review, we have summarized different types of retinal prostheses, implant locations, and visual outcomes. Our discussions will further elucidate the results from clinical trials, and the challenges that will need to be overcome to more efficaciously assist patients with AMD and RP in the future.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.